Q1 2024 Holdings
Filed 2024-05-13 | 113 holdings | $3.9B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-05-17) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cava Group Inc(CAVA) | COM | 148929102 | $1.9B | 26,507,990 | 47.3% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $282.1M | 117,553,284 | 7.2% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $200.0M | 11,259,438 | 5.1% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $121.7M | 3,027,135 | 3.1% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $86.8M | 3,036,668 | 2.2% |
| Morphic Hldg Inc | COM | 61775R105 | $77.9M | 2,213,188 | 2.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $77.3M | 1,315,282 | 2.0% |
| SpringWorks Therapeutics Inc | COM | 85205L107 | $69.7M | 1,415,348 | 1.8% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $65.1M | 1,390,477 | 1.7% |
| Beigene Ltd(ONC) | SPONSORED ADR | 07725L102 | $63.3M | 404,782 | 1.6% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $60.0M | 2,779,619 | 1.5% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $43.1M | 1,517,960 | 1.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $42.5M | 1,318,649 | 1.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $41.0M | 1,919,884 | 1.0% |
| Neumora Therapeutics Inc(NMRA) | COM | 640979100 | $40.2M | 2,924,052 | 1.0% |
| Korro Bio Inc(KRRO) | COM | 500946108 | $37.7M | 419,226 | 1.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $35.5M | 506,584 | 0.9% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $33.3M | 2,500,000 | 0.8% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $29.7M | 3,080,422 | 0.8% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $29.5M | 110,507 | 0.8% |
| GlycoMimetics Inc(GLYCEUR) | COM | 38000Q102 | $25.8M | 8,589,064 | 0.7% |
| Wave Life Sciences Ltd(WVE) | SHS | Y95308105 | $25.0M | 4,051,400 | 0.6% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $24.8M | 1,001,360 | 0.6% |
| Spdr Ser Tr(XBI)Call | S&P BIOTECH | 78464A870 | $23.7M | 250,000 | 0.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $21.8M | 506,019 | 0.6% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $20.8M | 253,863 | 0.5% |
| Merus N V | COM | N5749R100 | $20.5M | 455,081 | 0.5% |
| NewAmsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $18.9M | 800,000 | 0.5% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $17.4M | 2,194,841 | 0.4% |
| Arrowhead Pharmaceuticals Inc(ARWR)Call | COM | 04280A100 | $17.2M | 600,000 | 0.4% |
| Acelyrin Inc | COM | 00445A100 | $16.2M | 2,405,143 | 0.4% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $16.1M | 405,784 | 0.4% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $16.0M | 1,412,500 | 0.4% |
| Gossamer Bio Inc(GOSS) | COM | 38341P102 | $15.7M | 13,308,968 | 0.4% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $14.8M | 811,718 | 0.4% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $13.4M | 2,505,013 | 0.3% |
| Sea Ltd(SE) | SPONSORED ADS | 81141R100 | $12.8M | 237,500 | 0.3% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $12.6M | 801,716 | 0.3% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $12.4M | 884,214 | 0.3% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $11.9M | 1,011,776 | 0.3% |
| Generation Bio Co(GBIOGBX) | COM | 37148K100 | $11.5M | 2,830,591 | 0.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $10.9M | 253,387 | 0.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $10.6M | 253,000 | 0.3% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $10.6M | 3,687,548 | 0.3% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $10.3M | 502,899 | 0.3% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $10.1M | 152,500 | 0.3% |
| Erasca Inc(ERAS) | COM | 29479A108 | $9.7M | 4,721,194 | 0.2% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $9.1M | 15,631,235 | 0.2% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $9.0M | 4,750,000 | 0.2% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $8.3M | 177,932 | 0.2% |